Figure 1

CD4 + T cell analysis. A. CD3+ CD4+ T cells collected from PBL, ascites, primary tumor and omental metastases were analyzed for CD25 and FoxP3, upper panels and Ki-67 and Foxp3, lower panels. Percentage of CD25+ FoxP3+, Treg in PBL and TIL of CRC patients (n = 16) B, and in OVC patients (n = 22) C. Percentage of proliferating Treg in CRC samples (D) and in OVC samples (E).